RedHill Biopharma
NasdaqCM:RDHL
$ 0,83
$0,00 (0,00%)
0,83 $
$0,00 (0,00%)
End-of-day quote: 04/10/2026

Quick Analysis
The traffic-light system summarizes key characteristics and shows the investment’s quality at a glance.

Financials

Year Year 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012
EPS Earnings Per Share $-2.100,00 $-2.100,00 $-1.400,00 $-1.700,00 $-2.600,00 $-2.300,00 $-1.900,00 $-1.200,00 $-170,00 $-200,00
Earnings Earnings $-105,00M $-105,00M $-56,00M $-51,00M $-52,00M $-46,00M $-190,00M $-300,00M $-37,40M $-30,00M
RPS Revenue Per Share $1,72k $1,29k $157,25 $278,67 $200,50 $5,00 $0,00 $28,04 $0,05 $0,00
Revenue Revenue $85,76M $64,36M $6,29M $8,36M $4,01M $0,10M $0,00M $7,01M $0,01M $0,00M
OCF Operating Cash Flow $-65,05M $-48,58M $-40,75M $-34,46M $-44,77M $-28,26M $-17,83M $-12,23M $0,00M $0,00M
FCF Free Cash Flow $-65,16M $-48,99M $-40,92M $-34,49M $-44,92M $-28,82M $0,00M $0,00M $0,00M $0,00M
OM Operating Margin -94,61% -98,95% 0,00% 0,00% 0,00% 0,00% 0,00% -151,80% 0,00% 0,00%
GM % Gross Margin % 42,39% 42,68% 64,09% 66,06% 46,94% 100,00% 100,00% 85,03% 100,00% 100,00%
FCFS Free Cash Flow Per Share $-1.400,52 $-2.809,73 $-1.379,23 $-1.493,08 $-2.602,22 $-2.208,23 $-1.756,16 $-1,54 $-1,39 $-1,31
LT Debt Long-Term Debt $83,62M $81,39M N/A N/A N/A N/A N/A N/A N/A N/A
Sha. Stocks 0,05M 0,05M 0,04M 0,03M 0,02M 0,02M 0,1M 0,25M 0,22M 0,15M
×